ArticleClinical rheumatology2023

Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis.

Panpan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.